Semaglutide (Ozempic)

semaglutide · Novo Nordisk

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Semaglutide (Ozempic), covering 2026-03-04 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes [Phase 2]